- Home
- PLRX vs QSI Comparison
PLRX vs QSI Comparison
Compare PLRX & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLRX | QSI |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.3M | 273.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | PLRX | QSI |
|---|---|---|
| Price | $1.28 | $1.20 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $3.79 | $2.63 |
| AVG Volume (30 Days) | 915.7K | ★ 5.4M |
| Earning Date | 03-02-2026 | 03-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $3,177,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $159.68 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 40.20 |
| 52 Week Low | $1.10 | $0.95 |
| 52 Week High | $12.88 | $3.10 |
Technical Indicators
Market Signals| Indicator | PLRX | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.69 | 43.11 |
| Support Level | $1.26 | $1.18 |
| Resistance Level | $1.38 | $1.32 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 41.67 | 46.30 |
Price Performance
Historical ComparisonAbout PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.